Safety of Elacestrant in ER+/HER2- and ESR1 Mutations MBC

Clinical trial NCT06544577 · RECRUITING

Trial details

NCT number: NCT06544577
Sponsor: SciClone Pharmaceuticals
Status: RECRUITING
Study type: OBSERVATIONAL

ESR1 Gene Mutation Advanced Breast Cancer Safety

Start date: 2024-07-13
Primary completion: 2025-08-01
Enrollment: 350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.